|
| | Publication Year | Title | Author(s) |
| 1 | 1-Jan-2008 | Alterations in vascular architecture and permeability following OXi4503 treatment. | Chan, Lie Sam; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher |
| 2 | 8-Jul-2007 | Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis. | Chan, Lie Sam; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher |
| 3 | 15-Nov-2012 | Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments. | Nguyen, Linh; Fifis, Theodora; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Costa, Patricia Nunes Luiza; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher |
| 4 | 18-Aug-2013 | Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor. | Fifis, Theodora; Nguyen, Linh; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Nunes Costa, Patricia Luiza; Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Waltham, Mark; Thompson, Erik W; Christophi, Christopher |
